Industry news

The principal events in Russian science in 2013

Russia Beyonds The Headlines

The main event of 2013 came from outer space: in mid-February an asteroid 20-metres in size exploded over Chelyabinsk. This was the most powerful event in probably the last 100 years, since the catastrophe at Tunguska.

Emerging Pharmaceutical Clusters Attracting FDI Inflows in Russia

Before It's News

The combined contribution of various factors such as increasing support from the government, rise in the expenditure on healthcare, and growth in the investments made by the private players will result in a RUB 1.5 Trillion pharmaceutical market in Russia by 2017. Similar to earlier years, the commercial drugs segment was estimated to have occupied the largest market share in 2012. Besides, the state drug segment is continuously declining and losing its share to the commercial segment.

Research and Markets: The Russian Pharmaceutical Market is Anticipated to Grow at a CAGR of Around 11% During 2012-2017

Modernization of public health continues, Putin said

chemrar.ru

Program to modernize the health care system in Russia is not completed , it lasts for decades to come , a program to support rural doctors must continue , Russian President Vladimir Putin . " And at the federal and regional levels of healthcare modernization program , designed for decades to come , it will not be canceled in these activities, from 460 billion ( RUR ) " , - Putin said Thursday at a conference ONF . 
 

Russia Churns Out Skolkovo as Latest R&D Innovation Hub

Vitaly Shustikov, electronics360.globalspec.com

Skolkovo, a 100-acre industrial park and business incubator on the outskirts of Moscow, recently re-elected the Prime Minister of the Russian Federation, Dmitry Medvedev, as Skolkovo Foundation chairman.

Preferences for substance

Maria Dranishnikova, Vedomodti

Preference of 15% can get the company that packaged medicines in Russia ( these preferences will be valid until the end of 2014 - after such producers cease to be considered local , say two members of yesterday's meeting at Manturov), 30 % - manufacturers of finished dosage forms , 40 % - establish a complete production cycle , ie, including the production of substances. 

Russia's healthcare system coping with modern challenges

Larisa Smirnova, Russia & India Report

According to the Ministry of Public Health and Social Development, Russians can obtain at home most of the same aid available on the global healthcare market.

Business Council Meeting Sees Two New Partnerships

Anatoly Medetsky, The Moscow Times

Russian government officials, led by two deputy ministers, met with U.S. business representatives and lobbyists for a two-day conference in Houston to exchange their views on doing business in Russia.

Russia best place for investments – medical company executive

Ekaterina Scherbakova, The Voice of Russia

As the "Open Innovations" Forum in Moscow is in full swing presenting new cutting edge technologies, Steven Oesterle, Senior Vice President of Corporate Strategy and Innovation at Medtronic Inc., in an interview to Voice of Russia outlined what his company has to contribute to the global development of technology. 

Evaluation of Russian pharmaceutical market

Market Access Solutions

The company " Coface ", which is an expert in the field of commercial risks and the global leader in credit insurance , has introduced the first quarterly report on the evaluation of the Russian pharmaceutical market . Estimation of capacity of the pharmaceutical market as a whole and its individual elements may vary depending on the source of the information . This is due to the fact that different media outlets can use divergent ways of grouping types of pharmaceutical activity by sector. The ratio of domestic and imported drugs in the Russian market remained stable in 2011 - 1 half of 2013 , and in value terms, imports cover about 75 % of the market , and in-kind - only 40% ( in 2011 the share of slightly shifted in favor of imported goods).